Stock Track | UNITED LAB Plummets 5.06% Intraday After UBS Cuts Target Price on Weak Financials

Stock Track03-26

UNITED LAB's stock price plummeted 5.06% during intraday trading on Thursday, following the release of a research report from UBS.

The decline comes after UBS adjusted its forecasts for the company, reducing its target price from HK$18.9 to HK$17.6 while maintaining a "Buy" rating. The adjustment was made following UNITED LAB's full-year 2025 results, which showed a 4% year-on-year decline in revenue to RMB 13.2 billion and a 21.6% drop in net profit to RMB 2.1 billion. The second half performance was particularly weak, with net profit plunging 84% year-on-year to RMB 192 million.

UBS noted that the company's key candidate drug, UBT251, is progressing in global development, but management has guided for significant expenditures ahead, with R&D spending expected to exceed RMB 1 billion and capital expenditures of RMB 1.8 billion for the current year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1151521866?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-26 15:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151521866","market":"nz","top_or_hot":-1,"title":"Stock Track | UNITED LAB Plummets 5.06% Intraday After UBS Cuts Target Price on Weak Financials","media":"Stock Track","content":"<p>UNITED LAB's stock price plummeted 5.06% during intraday trading on Thursday, following the release of a research report from UBS.</p><p>The decline comes after UBS adjusted its forecasts for the company, reducing its target price from HK$18.9 to HK$17.6 while maintaining a \"Buy\" rating. The adjustment was made following UNITED LAB's full-year 2025 results, which showed a 4% year-on-year decline in revenue to RMB 13.2 billion and a 21.6% drop in net profit to RMB 2.1 billion. The second half performance was particularly weak, with net profit plunging 84% year-on-year to RMB 192 million.</p><p>UBS noted that the company's key candidate drug, UBT251, is progressing in global development, but management has guided for significant expenditures ahead, with R&D spending expected to exceed RMB 1 billion and capital expenditures of RMB 1.8 billion for the current year.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | UNITED LAB Plummets 5.06% Intraday After UBS Cuts Target Price on Weak Financials</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | UNITED LAB Plummets 5.06% Intraday After UBS Cuts Target Price on Weak Financials\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-26 15:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>UNITED LAB's stock price plummeted 5.06% during intraday trading on Thursday, following the release of a research report from UBS.</p><p>The decline comes after UBS adjusted its forecasts for the company, reducing its target price from HK$18.9 to HK$17.6 while maintaining a \"Buy\" rating. The adjustment was made following UNITED LAB's full-year 2025 results, which showed a 4% year-on-year decline in revenue to RMB 13.2 billion and a 21.6% drop in net profit to RMB 2.1 billion. The second half performance was particularly weak, with net profit plunging 84% year-on-year to RMB 192 million.</p><p>UBS noted that the company's key candidate drug, UBT251, is progressing in global development, but management has guided for significant expenditures ahead, with R&D spending expected to exceed RMB 1 billion and capital expenditures of RMB 1.8 billion for the current year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03933","symbol_name":"联邦制药","start_time":0,"source_url":"","article_id":"1151521866","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151521866","pubTimestamp":1774511226,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"UNITED LAB's stock price plummeted 5.06% during intraday trading on Thursday, following the release of a research report from UBS.The decline comes after UBS adjusted its forecasts for the company,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03933":"联邦制药"},"translate_title":"个股追踪|瑞银因财报疲弱下调目标价后联邦制药盘中暴跌5.06%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03933":1},"content_text":"UNITED LAB's stock price plummeted 5.06% during intraday trading on Thursday, following the release of a research report from UBS.The decline comes after UBS adjusted its forecasts for the company, reducing its target price from HK$18.9 to HK$17.6 while maintaining a \"Buy\" rating. The adjustment was made following UNITED LAB's full-year 2025 results, which showed a 4% year-on-year decline in revenue to RMB 13.2 billion and a 21.6% drop in net profit to RMB 2.1 billion. The second half performance was particularly weak, with net profit plunging 84% year-on-year to RMB 192 million.UBS noted that the company's key candidate drug, UBT251, is progressing in global development, but management has guided for significant expenditures ahead, with R&D spending expected to exceed RMB 1 billion and capital expenditures of RMB 1.8 billion for the current year.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1151521866","isCrawlerRequest":true}